Home
Affinity Asset Advisors reported a 6.4% stake in NextCure NXTC · 274,073 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 6.4%
- Last report
- 9.99% · filed 26/01/29
- Shares held
- 274,073 sh
- Class
- Common Stock, $0.001 par value per share
- Stock
- NextCure NXTC
- Holder
- Affinity Asset Advisors
- Event date
- 26/06/30
- Filed
- 26/08/13
6.4% stake · −3.6pp from the last report
- Stake
- 6.4%
- Last report
- 9.99%
- Since last report
- −3.6pp
NextCure trades, last 26 weeks
What else happened in NextCure around then
Filed or reported within 30 days of the trade day · 05/31~07/30Affinity Asset Advisors's other 5% stake reports
- Affinity Asset Advisors
5% stakeLexeo Therapeutics
5% stakeLexeo Therapeutics
LXEO
8.4% stake
6,674,913 sh
8.4% stake
Filed 08/13
- Affinity Asset Advisors
5% stakeEquillium
5% stakeEquillium
EQ
6.5% stake
4,100,000 sh
6.5% stake
Filed 08/13
- Affinity Asset Advisors
5% stakeAmanat Acquisition
5% stakeAmanat Acquisition
AMAN
5% stake
375,000 sh
5% stake
Filed 08/13
- Affinity Asset Advisors
5% stakeFirst Tracks Biotherapeutics
5% stakeFirst Tracks Biotherapeutics
TRAX
5.8% stake
2,032,012 sh
5.8% stake
Filed 08/13
- Affinity Asset Advisors
5% stakeOvid Therapeutics
5% stakeOvid Therapeutics
OVID
7.9% stake
15,143,728 sh
7.9% stake
Filed 08/13
